Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Brief episodes of numbness are common, but ongoing or unexplained sensations could indicate serious health conditions requiring medical assessment, from nerve damage to diabetes-related complications. Numbness and tingling in the hands, feet, arms or legs is often brief and harmless,…
Genprex moves closer to clinical testing of its diabetes gene therapy through a new manufacturing partnership, amid ongoing efforts to build its pipeline despite high investor caution. Genprex has moved a step closer to advancing its diabetes gene therapy programme…
Amylyx Pharmaceuticals’ stock jumped 21% in pre-market trading following positive Phase 3 trial results for its experimental drug avexitide, signalling potential breakthrough in post-bariatric hypoglycaemia treatment. Amylyx Pharmaceuticals shares jumped in pre-market trading on Tuesday after the company said avexitide,…
A Swedish nationwide study reveals that patients with acromegaly-related diabetes face a significantly higher cardiovascular burden than those with type 2 diabetes alone, highlighting the need for targeted risk management. People with acromegaly-associated diabetes appear to face a heavier cardiovascular…
Researchers clarify their dosing strategies in a study examining semaglutide’s effects on osteoblast ferroptosis, addressing criticisms over dosage relevance and pathway analysis, and emphasising its mechanistic focus. Researchers behind a study on semaglutide and diabetic periodontitis have pushed back against…
The diabetic kidney disease sector is projected to reach $3.76 billion by 2030, driven by advancements in personalised medicine, early screening, and artificial intelligence, reshaping preventative care practices. The diabetic kidney disease market is expected to keep expanding steadily through…
Recent research uncovers the role of the gene TEAD1 in the tissue changes driving diabetic erectile dysfunction, revealing new possibilities for targeted therapies beyond blood sugar control. New research suggests that a gene called TEAD1 may help drive the tissue…
The worldwide market for diabetes treatments is projected to reach $163.79 billion by 2034, driven by demographic shifts and innovative drug classes that are transforming care beyond glucose management. The global market for diabetes medicines is expected to reach $163.79…
Amid South-West Florida’s storm season, experts emphasise the importance of proactive foot care for people with diabetes. From preparing a dedicated kit to daily inspections, steps taken weeks in advance can prevent serious injuries and complications when floodwaters and power…
Amylyx Pharmaceuticals is set to announce the topline results of its pivotal Phase 3 LUCIDITY trial testing avexitide, a potential treatment for post-bariatric hypoglycaemia, on 18 August, as the company prepares for a possible market launch in 2027. Amylyx Pharmaceuticals…
The Department of Health and Human Services has issued a favourable advisory opinion on community health programmes providing produce boxes and vouchers to low-income patients, signalling cautious acceptance of the growing The federal health watchdog has signalled cautious support for…
A new simulator study indicates that peripheral neuropathy in diabetics could cause misjudged pedal presses, potentially increasing accident risk among drivers with nerve damage. A new simulator study suggests that diabetic nerve damage in the feet may do more than…
